Analysis by a highly sensitive split luciferase assay of the regions involved in APP dimerization and its impact on processing

FEBS Open Bio

Volumn 5, Issue , 2015, Pages 763-773

  Decock, Marie ^a   El Haylani, Laetitia ^a   Stanga, Serena ^a   Dewachter, Ilse ^a   Octave, Jean Noël ^a   Smith, Steven O ^b   Constantinescu, Stefan N ^a   Kienlen Campard, Pascal ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Amyloid beta peptide; APP; Dimerization; GXXXG motifs; Split luciferase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PEPTIDE FRAGMENT; TRANSCRIPTION FACTOR GCN4;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BRAIN FUNCTION; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIMERIZATION; FEMALE; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; LIMIT OF QUANTITATION; LUCIFERASE ASSAY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; SPLIT LUCIFERASE ASSAY; WESTERN BLOTTING;

EID: 84941955419     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2015.09.002     Document Type: Article

References (50)

1. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325:733-736.
2. Selkoe D.J. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 2004, 140:627-638.
3. Octave J.N. The amyloid peptide and its precursor in Alzheimer's disease. Rev. Neurosci. 1995, 6:287-316.
4. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984, 120:885-890.
5. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
6. Shariati S.A., De S.B. Redundancy and divergence in the amyloid precursor protein family. FEBS Lett. 2013, 587:2036-2045.
7. Weyer S.W., Klevanski M., Delekate A., Voikar V., Aydin D., Hick M., Filippov M., Drost N., Schaller K.L., Saar M., Vogt M.A., Gass P., Samanta A., Jaschke A., Korte M., Wolfer D.P., Caldwell J.H., Muller U.C. APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J. 2011, 30:2266-2280.
8. Klevanski M., Saar M., Baumkotter F., Weyer S.W., Kins S., Muller U.C. Differential role of APP and APLPs for neuromuscular synaptic morphology and function. Mol. Cell Neurosci. 2014, 61:201-210.
9. Khalifa N.B., Van H.J., Tasiaux B., Huysseune S., Smith S.O., Constantinescu S.N., Octave J.N., Kienlen-Campard P. What is the role of amyloid precursor protein dimerization?. Cell Adh. Migr. 2010, 4:268-272.
10. Coulson E.J., Paliga K., Beyreuther K., Masters C.L. What the evolution of the amyloid protein precursor supergene family tells us about its function. Neurochem. Int. 2000, 36:175-184.
11. Soba P., Eggert S., Wagner K., Zentgraf H., Siehl K., Kreger S., Lower A., Langer A., Merdes G., Paro R., Masters C.L., Muller U., Kins S., Beyreuther K. Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO J. 2005, 24:3624-3634.
12. Kaden D., Voigt P., Munter L.M., Bobowski K.D., Schaefer M., Multhaup G. Subcellular localization and dimerization of APLP1 are strikingly different from APP and APLP2. J. Cell Sci. 2009, 122:368-377.
13. Chen C.D., Oh S.Y., Hinman J.D., Abraham C.R. Visualization of APP dimerization and APP-Notch2 heterodimerization in living cells using bimolecular fluorescence complementation. J. Neurochem. 2006, 97:30-43.
14. Shaked G.M., Kummer M.P., Lu D.C., Galvan V., Bredesen D.E., Koo E.H. Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J. 2006, 20:1254-1256.
15. Kaden D., Munter L.M., Joshi M., Treiber C., Weise C., Bethge T., Voigt P., Schaefer M., Beyermann M., Reif B., Multhaup G. Homophilic interactions of the amyloid precursor protein (APP) ectodomain are regulated by the loop region and affect beta-secretase cleavage of APP. J. Biol. Chem. 2008, 283:7271-7279.
16. Isbert S., Wagner K., Eggert S., Schweitzer A., Multhaup G., Weggen S., Kins S., Pietrzik C.U. APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms. Cell Mol. Life Sci. 2012, 69:1353-1375.
17. Ben K.N., Tyteca D., Courtoy P.J., Renauld J.C., Constantinescu S.N., Octave J.N., Kienlen-Campard P. Contribution of Kunitz protease inhibitor and transmembrane domains to amyloid precursor protein homodimerization. Neurodegener. Dis. 2012, 10:92-95.
18. Munter L.M., Voigt P., Harmeier A., Kaden D., Gottschalk K.E., Weise C., Pipkorn R., Schaefer M., Langosch D., Multhaup G. GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO J. 2007, 26:1702-1712.
19. Kienlen-Campard P., Tasiaux B., Van H.J., Li M., Huysseune S., Sato T., Fei J.Z., Aimoto S., Courtoy P.J., Smith S.O., Constantinescu S.N., Octave J.N. Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs. J. Biol. Chem. 2008, 283:7733-7744.
20. Russ W.P., Engelman D.M. The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol. 2000, 296:911-919.
21. Brosig B., Langosch D. The dimerization motif of the glycophorin A transmembrane segment in membranes: importance of glycine residues. Protein Sci. 1998, 7:1052-1056.
22. Gorman P.M., Kim S., Guo M., Melnyk R.A., McLaurin J., Fraser P.E., Bowie J.U., Chakrabartty A. Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants. BMC Neurosci. 2008, 9:17.
23. Munter L.M., Botev A., Richter L., Hildebrand P.W., Althoff V., Weise C., Kaden D., Multhaup G. Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. J. Biol. Chem. 2010, 285:21636-21643.
24. Hendriks L., van Duijn C.M., Cras P., Cruts M., Van H.W., van H.F., Warren A., McInnis M.G., Antonarakis S.E., Martin J.J. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat. Genet. 1992, 1:218-221.
25. Scheuermann S., Hambsch B., Hesse L., Stumm J., Schmidt C., Beher D., Bayer T.A., Beyreuther K., Multhaup G. Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J. Biol. Chem. 2001, 276:33923-33929.
26. Eggert S., Midthune B., Cottrell B., Koo E.H. Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production. J. Biol. Chem. 2009, 284:28943-28952.
27. So P.P., Khodr C.E., Chen C.D., Abraham C.R. Comparable dimerization found in wildtype and familial Alzheimer's disease amyloid precursor protein mutants. Am. J. Neurodegener. Dis. 2013, 2:15-28.
28. Sato T., Tang T.C., Reubins G., Fei J.Z., Fujimoto T., Kienlen-Campard P., Constantinescu S.N., Octave J.N., Aimoto S., Smith S.O. A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis. Proc. Natl. Acad. Sci. USA 2009, 106:1421-1426.
29. Tang T.C., Hu Y., Kienlen-Campard P., El H.L., Decock M., Van H.J., Fu Z., Octave J.N., Constantinescu S.N., Smith S.O. Conformational changes induced by the A21G Flemish mutation in the amyloid precursor protein lead to increased Abeta production. Structure 2014, 22:387-396.
30. Song Y., Hustedt E.J., Brandon S., Sanders C.R. Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein. Biochemistry 2013, 52:5051-5064.
31. Ben K.N., Tyteca D., Marinangeli C., Depuydt M., Collet J.F., Courtoy P.J., Renauld J.C., Constantinescu S., Octave J.N., Kienlen-Campard P. Structural features of the KPI domain control APP dimerization, trafficking, and processing. FASEB J. 2012, 26:855-867.
32. So P.P., Zeldich E., Seyb K.I., Huang M.M., Concannon J.B., King G.D., Chen C.D., Cuny G.D., Glicksman M.A., Abraham C.R. Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-beta precursor protein dimerization. Am. J. Neurodegener. Dis. 2012, 1:75-87.
33. Asada-Utsugi M., Uemura K., Noda Y., Kuzuya A., Maesako M., Ando K., Kubota M., Watanabe K., Takahashi M., Kihara T., Shimohama S., Takahashi R., Berezovska O., Kinoshita A. N-cadherin enhances APP dimerization at the extracellular domain and modulates Abeta production. J. Neurochem. 2011, 119:354-363.
34. Libeu C.A., Descamps O., Zhang Q., John V., Bredesen D.E. Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain. PLoS One 2012, 7:e40027.
35. Richter L., Munter L.M., Ness J., Hildebrand P.W., Dasari M., Unterreitmeier S., Bulic B., Beyermann M., Gust R., Reif B., Weggen S., Langosch D., Multhaup G. Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proc. Natl. Acad. Sci. USA 2010, 107:14597-14602.
36. Jung J.I., Premraj S., Cruz P.E., Ladd T.B., Kwak Y., Koo E.H., Felsenstein K.M., Golde T.E., Ran Y. Independent relationship between amyloid precursor protein (APP) dimerization and gamma-secretase processivity. PLoS One 2014, 9:e111553.
37. Remy I., Michnick S.W. A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat. Methods 2006, 3:977-979.
38. Marinangeli C., Tasiaux B., Opsomer R., Hage S., Sodero A.O., Dewachter I., Octave J.N., Smith S.O., Constantinescu S.N., Kienlen-Campard P. Presenilin transmembrane domain 8 conserved AXXXAXXXG motifs are required for the activity of the gamma-secretase complex. J. Biol. Chem. 2015, 290:7169-7184.
39. Hage S., Stanga S., Marinangeli C., Octave J.N., Dewachter I., Quetin-Leclercq J., Kienlen-Campard P. Characterization of Pterocarpus erinaceus kino extract and its gamma-secretase inhibitory properties. J. Ethnopharmacol. 2015, 163:192-202.
40. Annaert W.G., Levesque L., Craessaerts K., Dierinck I., Snellings G., Westaway D., George-Hyslop P.S., Cordell B., Fraser P., De S.B. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J. Cell Biol. 1999, 147:277-294.
41. Devauges V., Marquer C., Lecart S., Cossec J.C., Potier M.C., Fort E., Suhling K., Leveque-Fort S. Homodimerization of amyloid precursor protein at the plasma membrane: a homoFRET study by time-resolved fluorescence anisotropy imaging. PLoS One 2012, 7:e44434.
42. Kerppola T.K. Complementary methods for studies of protein interactions in living cells. Nat. Methods 2006, 3:969-971.
43. Horstman A., Tonaco I.A., Boutilier K., Immink R.G. A cautionary note on the use of split-YFP/BiFC in plant protein-protein interaction studies. Int. J. Mol. Sci. 2014, 15:9628-9643.
44. Smith S.O., Song D., Shekar S., Groesbeek M., Ziliox M., Aimoto S. Structure of the transmembrane dimer interface of glycophorin A in membrane bilayers. Biochemistry 2001, 40:6553-6558.
45. Lemmon M.A., Flanagan J.M., Treutlein H.R., Zhang J., Engelman D.M. Sequence specificity in the dimerization of transmembrane alpha-helices. Biochemistry 1992, 31:12719-12725.
46. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T., Murayama Y., Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 1993, 362:75-79.
47. Fiore F., Zambrano N., Minopoli G., Donini V., Duilio A., Russo T. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 1995, 270:30853-30856.
48. Guenette S.Y., Chen J., Jondro P.D., Tanzi R.E. Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 1996, 93:10832-10837.
49. Borg J.P., Ooi J., Levy E., Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell Biol. 1996, 16:6229-6241.
50. Selkoe D.J., Yamazaki T., Citron M., Podlisny M.B., Koo E.H., Teplow D.B., Haass C. The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Ann. N. Y. Acad. Sci. 1996, 777:57-64.